Venous Thromboembolism Archives

AstraZeneca finds no evidence of increased blood clot risk from vaccine

AstraZeneca, Blood Clots, Clinical Trials, COVID-19 Vaccines, Deep Vein Thrombosis (DVT), European Medicines Agency, European Union, R&D, Safety Data, United Kingdom

AstraZeneca Plc said on March 14 a review of safety data of people vaccinated with the company’s Covid-19 vaccine has shown no evidence of an increased risk of blood clots.

J&J’s Xarelto Approved for 8th Indication by U.S. FDA

Anticoagulants, Approvals, Blockbusters, Blood Clots, Collaborations, FDA, FDA/Regulatory, Hospitals, Injectables, Medical Guidelines, New Indications, Venous Thromboembolism

The U.S. FDA approved Janssen’s Xarelto (rivaroxaban) for preventing blood clots in acutely sick patients in hospitals who are at risk for blood clots but who are not at high risk of bleeding.

FDA approves first anticoagulant for pediatric patients to treat potentially life-threatening blood clots

Anticoagulants, Approvals, Blood Thinner, Boxed Warning, Congenital Heart Disease, FDA, FDA/Regulatory, New Indications, Priority Review Status, Symptomatic Venous Thromboembolism (VTE)

The U.S. FDA approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism in pediatric patients 1 month of age and older.